Treatment of atypical hemolytic uremic syndrome with eculizumab in a patient presenting with neuropsychiatric prodrome: a case report

Atypical hemolytic uremic syndrome (aHUS) is a rare thrombotic microangiopathy (TMA) caused by dysregulation of the complement system. It is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury. Owing to its diverse and nonspecific clinical manifestations, ea...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Hanze Yang, Jingdong Zhang, Hao Wu, Hongzhao Xu, Zhonggao Xu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-04-01
Subjects:	atypical hemolytic uremic syndrome thrombotic microangiopathy eculizumab neuropsychiatric prodrome intermittent seizures posterior reversible encephalopathy syndrome
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1542973/full